Celanese Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US1508701034
USD
39.84
-2 (-4.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.57 M

Shareholding (Mar 2025)

FII

19.69%

Held by 296 FIIs

DII

0

Held by 102 DIIs

Promoter

0.00%

How big is Celanese Corp.?

22-Jun-2025

As of Jun 18, Celanese Corp. has a market capitalization of 9,258.74 million and reported net sales of 10,058.00 million with a net profit loss of 1,642.00 million for the latest four quarters. As of Dec 24, the company has shareholder's funds of 5,175.00 million and total assets of 22,857.00 million.

As of Jun 18, Celanese Corp. has a market capitalization of 9,258.74 million, classifying it as a Large Cap company.<BR><BR>As of Jun 24, the company reported net sales of 10,058.00 million for the latest four quarters. However, it also experienced a net profit loss of 1,642.00 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds amounting to 5,175.00 million and total assets of 22,857.00 million.

Read More

What does Celanese Corp. do?

22-Jun-2025

Celanese Corporation is a technology and specialty materials company in the specialty chemicals industry, with a market cap of approximately $9.26 billion. As of March 2025, it reported net sales of $2.39 billion and a net profit of -$12 million.

Overview:<BR>Celanese Corporation is a technology and specialty materials company operating in the specialty chemicals industry, with a market capitalization in the large-cap bracket.<BR><BR>Financial Snapshot:<BR>- Net Sales: 2,389 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: -12 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 9,258.74 Million (Large Cap)<BR><BR>Key Metrics:<BR>- Dividend Yield: 1.72%<BR>- Debt Equity: 2.30<BR>- Return on Equity: -1.64%<BR>- Price to Book: 1.79<BR><BR>Contact Details:<BR>- Address: 222 Las Colinas Blvd W Ste 900N, IRVING TX: 75039-5467<BR>- Tel: ['1 972 4434000', '1 972 4433728']<BR>- Fax: 1 302 6555049<BR>- Website: https://www.celanese.com/

Read More

Who are in the management team of Celanese Corp.?

22-Jun-2025

As of March 2022, the management team of Celanese Corp. includes Ms. Lori Ryerkerk (Chairman, President, CEO), Mr. Edward Galante (Lead Independent Director), and several independent directors: Ms. Deborah Kissire, Ms. Jean Blackwell, Mr. William Brown, and Ms. Kathryn Hill. They guide the company's strategic direction and oversee operations.

As of March 2022, the management team of Celanese Corp. includes the following individuals:<BR><BR>- Ms. Lori Ryerkerk: Chairman of the Board, President, Chief Executive Officer<BR>- Mr. Edward Galante: Lead Independent Director<BR>- Ms. Deborah Kissire: Director<BR>- Ms. Jean Blackwell: Independent Director<BR>- Mr. William Brown: Independent Director<BR>- Ms. Kathryn Hill: Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

Read More

Is Celanese Corp. overvalued or undervalued?

20-Sep-2025

As of February 18, 2025, Celanese Corp. is considered risky and overvalued due to its high EV/EBITDA ratio of 11.97, negative ROE of -1.64%, and significantly higher P/E ratio of 144.70 compared to peers, alongside poor stock performance with a year-to-date return of -34.29% versus the S&P 500's 12.22%.

As of 18 February 2025, the valuation grade for Celanese Corp. has moved from expensive to risky, indicating a shift in perception regarding its market value. Based on the current metrics, Celanese appears to be overvalued, particularly given its high EV to EBITDA ratio of 11.97 and a Price to Book Value of 1.82, which suggest that the stock is trading at a premium relative to its assets. Additionally, the company's return on equity (ROE) is notably negative at -1.64%, further reinforcing concerns about its profitability.<BR><BR>In comparison to its peers, Celanese Corp. has a significantly higher P/E ratio of 144.70 compared to Westlake Corp.'s 82.20 and Albemarle Corp.'s -101.94, indicating that investors are paying much more for each dollar of earnings, or in this case, losses. The stock has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -34.29% compared to the index's 12.22%, and a staggering -64.01% over the past year against the S&P 500's 17.14%. This performance further suggests that Celanese is not only overvalued but also struggling significantly in the current market environment.

Read More

Is Celanese Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Celanese Corp. is in a bearish trend with weak strength, indicated by negative MACD readings and underperformance against the S&P 500, showing a year-to-date return of -34.29% compared to the S&P's 12.22%.

As of 8 September 2025, the technical trend for Celanese Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by bearish MACD readings on both weekly and monthly time frames, as well as bearish signals from Bollinger Bands and KST. The daily moving averages also reflect a bearish outlook. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating some mixed signals. Dow Theory and OBV show no trend in both weekly and monthly assessments.<BR><BR>In terms of performance, Celanese has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -34.29% compared to the S&P's 12.22%, and a one-year return of -64.01% versus the S&P's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared Negative results for the last 3 consecutive quarters

  • NET PROFIT(9M) At USD -110 MM has Grown at -110.12%
  • OPERATING CASH FLOW(Y) Lowest at USD 1,020 MM
  • ROCE(HY) Lowest at -25.69%
2

Risky -

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 7,910 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.09%

stock-summary
Debt Equity

2.25

stock-summary
Return on Equity

1.04%

stock-summary
Price to Book

1.50

Revenue and Profits:
Net Sales:
2,532 Million
(Quarterly Results - Jun 2025)
Net Profit:
212 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.19%
0%
-14.19%
6 Months
-27.13%
0%
-27.13%
1 Year
-43.81%
0%
-43.81%
2 Years
-71.82%
0%
-71.82%
3 Years
-63.49%
0%
-63.49%
4 Years
-74.03%
0%
-74.03%
5 Years
-69.96%
0%
-69.96%

Celanese Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.88%
EBIT Growth (5y)
4.46%
EBIT to Interest (avg)
6.54
Debt to EBITDA (avg)
4.95
Net Debt to Equity (avg)
2.30
Sales to Capital Employed (avg)
0.53
Tax Ratio
42.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.64%
ROE (avg)
32.55%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.82
EV to EBIT
21.34
EV to EBITDA
11.97
EV to Capital Employed
1.25
EV to Sales
2.12
PEG Ratio
NA
Dividend Yield
1.69%
ROCE (Latest)
5.85%
ROE (Latest)
-1.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 118 Schemes (86.41%)

Foreign Institutions

Held by 296 Foreign Institutions (19.69%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.99% vs 0.80% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1,866.67% vs 99.37% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,532.00",
          "val2": "2,389.00",
          "chgp": "5.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "442.00",
          "val2": "365.00",
          "chgp": "21.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "175.00",
          "val2": "201.00",
          "chgp": "-12.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-127.00",
          "val2": "23.00",
          "chgp": "-652.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "212.00",
          "val2": "-12.00",
          "chgp": "1,866.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "98.30%",
          "val2": "72.80%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.03% vs 13.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -176.33% vs 3.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,280.00",
          "val2": "10,940.00",
          "chgp": "-6.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,893.00",
          "val2": "1,936.00",
          "chgp": "-2.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "669.00",
          "val2": "720.00",
          "chgp": "-7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,678.00",
          "val2": "-73.00",
          "chgp": "-2,198.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,506.00",
          "val2": "1,973.00",
          "chgp": "-176.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.00%",
          "val2": "112.00%",
          "chgp": "-0.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2,532.00
2,389.00
5.99%
Operating Profit (PBDIT) excl Other Income
442.00
365.00
21.10%
Interest
175.00
201.00
-12.94%
Exceptional Items
-127.00
23.00
-652.17%
Consolidate Net Profit
212.00
-12.00
1,866.67%
Operating Profit Margin (Excl OI)
98.30%
72.80%
2.55%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.99% vs 0.80% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 1,866.67% vs 99.37% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
10,280.00
10,940.00
-6.03%
Operating Profit (PBDIT) excl Other Income
1,893.00
1,936.00
-2.22%
Interest
669.00
720.00
-7.08%
Exceptional Items
-1,678.00
-73.00
-2,198.63%
Consolidate Net Profit
-1,506.00
1,973.00
-176.33%
Operating Profit Margin (Excl OI)
108.00%
112.00%
-0.40%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -6.03% vs 13.10% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -176.33% vs 3.30% in Dec 2023

stock-summaryCompany CV
About Celanese Corp. stock-summary
stock-summary
Celanese Corp.
Specialty Chemicals
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company's segments include Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, Acetyl Intermediates and Other Activities. The Advanced Engineered Materials segment includes the Company's engineered materials business and certain affiliates. The Consumer Specialties segment includes the Company's cellulose derivatives and food ingredients businesses, which serve consumer-driven applications. The Industrial Specialties segment includes the Company's emulsion polymers and ethylene vinyl acetate (EVA) polymers businesses. The Acetyl Intermediates segment includes the Company's intermediate chemistry business, which produces and supplies acetyl products, including acetic acid, vinyl acetate monomer (VAM), acetic anhydride and acetate esters. The Company has operations in North America, Europe and Asia. As of December 31, 2016, the Company had 30 global production facilities.
Company Coordinates stock-summary
Company Details
222 Las Colinas Blvd W Ste 900N , IRVING TX : 75039-5467
stock-summary
Tel: 1 972 44340001 972 4433728
stock-summary
Registrar Details